Status:

COMPLETED

Evaluation of the Efficiency of Local Application of Bee Products in the Care of Diaper Dermatitis in Infants

Lead Sponsor:

Karadeniz Technical University

Conditions:

Diaper Dermatitis Healing

Eligibility:

All Genders

1-6 years

Phase:

NA

Brief Summary

The aim of this study was to evaluate the local application of bee products in the care of diaper dermatitis in infants. 1. H1: Barrier cream 1, consisting of a mixture of propolis, beeswax, queen be...

Detailed Description

Diaper dermatitis is one of the most common dermatological problems of infancy. Diaper dermatitis constitute from approximately 25% of visits to primary health care services for dermatological complai...

Eligibility Criteria

Inclusion

  • Infants aged 1-6 months registered at Family Health Centers No. 1, No. 2 and No. 3,
  • Infants aged 1-6 months admitted to Kumluca State Hospital's Pediatric Outpatient Clinic,
  • Infants with grade one diaper dermatitis according to the Uncomplicated Diaper Dermatitis in Infants Severity Rating Scale,
  • Breastfed babies,
  • Babies without antibiotics,
  • Families who do not regularly use protective barrier cream/oil for diaper dermatitis care,
  • Babies who have not started supplementary food,
  • Babies with no other dermatologic or allergic skin conditions,
  • Families who agreed to participate in the study were included.

Exclusion

  • Babies who are not registered to the Family Health Centers where the research was conducted,
  • Newborns and babies older than 6 months who apply to the Pediatric Outpatient Clinic of Kumluca State Hospital,
  • Babies who do not have first degree diaper dermatitis according to the Uncomplicated Diaper Dermatitis Severity Rating Scale in Infants,
  • Babies fed with breast milk + formula or only formula,
  • Babies using antibiotics,
  • Families who regularly use protective barrier cream/oil in diaper dermatitis care,
  • Babies who switch to solid food,
  • Babies with dermatological or other allergic skin problems,
  • Babies using antimycotic drugs (Ampotericin etc.),
  • Babies who use a bladder for a long time,
  • Babies with urinary incontinence due to diseases such as meningomyolocele and cerebral palsy,
  • Families who did not agree to participate in the research were not included.

Key Trial Info

Start Date :

December 24 2022

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

November 8 2023

Estimated Enrollment :

93 Patients enrolled

Trial Details

Trial ID

NCT06134505

Start Date

December 24 2022

End Date

November 8 2023

Last Update

January 17 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Antalya Provincial Directorate of Health

Antalya, Kumluca/Antalya, Turkey (Türkiye), 07000